Concentrix stock jumps as CNXC sets 2026 cash-flow target after $1.5 billion goodwill write-down
Concentrix shares rose 3.9% to $40.71 Wednesday after the company posted Q4 revenue of $2.55 billion and a $1.52 billion goodwill impairment charge. Adjusted profit and cash flow held steady, but BofA and Baird cut price targets, citing margin pressure. Concentrix forecast 2026 revenue of up to $10.18 billion and non-GAAP EPS as high as $12.07.